I get the argument against - if they can't sell V, what makes them think that they can sell anything else.
But then I think that because V is such a great product and Amarin has such a big head start on research of it, that they should develop combo products to go with V.
I would be very much against them acquiring any drug that will be administered INDEPENDENT of V.
Zip .... And diversification into other markets - like every country in Europe -they aren’t going to go into gold mining They need their cash to run the business so most unlikely they would be buying another company It is all just very vague and nothing to get excited about Alm